Superconductivity in Ru substituted BaFe2-xRuxAs2

The occurrence of bulk superconductivity at ~22 K is reported in polycrystalline samples of BaFe2-xRuxAs2 for nominal Ru content in the range of x=0.75 to 1.125. A systematic suppression of the spin density wave transition temperature (TSDW) precedes the appearance of superconductivity in the system. A phase diagram is proposed based on the measured TSDW and superconducting transition temperature (TC) variations as a function of Ru composition. Band structure calculations, indicate introduction of electron carriers in the system upon Ru substitutiom. The calculated magnetic moment on Fe shows a minimum at x=1.0, suggesting that the suppression of the magnetic moment is associated with the emergence of superconductivity. Results of low temperature and high field Mossbauer measurements are presented. These indicate weakening of magnetic interaction with Ru substitutionComment: 20 pages 10 figure

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

Visceral leishmaniasis (VL) is a serious health problem in the Indian subcontinent affecting the rural poor. It has a significant economic impact on concerned households. The development of drug resistance is a major problem and threatens control efforts under the VL elimination initiative. With an unprecedented choice of antileishmanial drugs (but no newer compound in clinical development), policies that protect these drugs against the emergence of resistance are required. A possible strategy that has been successfully used for malaria and tuberculosis is the use of combination therapies. This study is the first comprehensive assessment of the cost-effectiveness of all possible mono- and combination therapies for the treatment of visceral leishmaniasis in the Indian subcontinent. The analysis was done from the societal perspective, including both health provider and household costs. The present work shows that combination treatments are a cost-effective alternative to current monotherapy for VL. Given their expected impact on emergence of drug resistance, the use of combination therapy should be considered in the context of the VL elimination programme in the Indian subcontinent

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

Resistance to antimonials has emerged as a major hurdle to the treatment and control of VL and led to the introduction of Miltefosine as first line treatment in the Indian subcontinent. MIL is an oral drug with a long half-life, and it is feared that resistance may emerge rapidly, threatening control efforts under the VL elimination program. There is an urgent need for monitoring treatment efficacy and emergence of drug resistance in the field. In a set of VL/PKDL cases recruited for MIL treatment, we observed comparable drug susceptibility in pre- and post-treatment isolates from cured VL patients while MIL susceptibility was significantly reduced in isolates from VL relapse and PKDL cases. The PKDL isolates showed higher tolerance to MIL as compared to VL isolates. Both VL and PKDL isolates were uniformly susceptible to PMM. MIL transporter genes LdMT/LdRos3 were previously reported as potential resistance markers in strains in which MIL resistance was experimentally induced. The point mutations and the down-regulated expression of these transporters observed in vitro could, however, not be verified in natural populations of parasites. LdMT/LdRos3 genes therefore, do not appear to be suitable markers so far for monitoring drug susceptibility in clinical leishmanial isolates

Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008

INTRODUCTION: Cancer vaccination has been researched as a means of treating and preventing cancer, but successful translational efforts yielding clinical therapeutics have been limited. Numerous reasons have been offered in explanation, pertaining both to the vaccine formulation, and the clinical trial methodology used. This study aims to characterize the tumor vaccine clinical trial landscape quantitatively, and explore the possible validity of the offered explanations including the translational obstacles posed by the current common endpoints. METHODS: We performed a detailed cross-sectional and longitudinal analysis of tumor vaccine trials (n=955) registered in the US Clinical Trials database. RESULTS: The number of tumor vaccine trials initiated per annum has declined 30% since a peak in 2008. In terms of vaccine formulation, 25% of trials use tumor cell/lysate preparations; whereas, 73% of trials vaccinate subjects against defined protein/peptide antigens. Also, 68% of trials do not use vectors for antigen delivery. Both these characteristics of tumor vaccines have remained unchanged since 1996. The top five types of cancer studied are: melanoma (22.6%); cervical cancer (13.0%); breast cancer (11.3%); lung cancer (9.5%); and prostate cancer (9.4%). In addition, 86% of the trials are performed where there is established disease rather than prophylactically, of which 67% are performed exclusively in the adjuvant setting. Also, 42% of Phase II trials do not measure any survival-related endpoint, and only 23% of Phase III trials assess the immune response to vaccination. CONCLUSION: The clinical trial effort in tumor vaccination is declining, necessitating a greater urgency in identifying and removing the obstacles to clinical translation. These obstacles may include: 1) vaccination against a small range of antigens; 2) naked delivery of antigen; 3) investigation of less immunogenic cancer types; and 4) investigation in the setting of established disease. In addition, the prevalence of late phase failure may be due to inadequate assessment of survival-related endpoints in Phase II trials. The clinical trial development of tumor vaccines should include mechanism-based translational endpoints, as well as the discovery of immune biomarkers with which to stratify, monitor, and prognosticate patients

Structure and vibrational properties of carbon tubules

The structure of multilayered carbon tubules has been investigated by electron microscopy and X-ray diffraction. The structure of tubules is characterized by disorder in the stacking of cylindrical graphene sheets. Raman scattering measurements have been carried out in tubules and compared with graphite. The observed features in the Raman spectra in tubules can be understood in terms of the influence of disorder. The additional Raman modes predicted for single layer carbon tubules have not been observed

Kinetics and mechanism of halogenation of aniline, p-toluidine and o-toluidine using N-chloro-p-toluene sulphonamide (CAT) under buffer conditions in ethanol -water mixtures

Abstract: Kinetics of halogenation of aniline, p-toluidine and o-toluidine have been investigated by using N- Keywords: Halogenation , CAT , Amines , Reactivity of amines Aim: The present work deals with the halogenation of aromatic amines (Aniline, o-toluidine and p-toluidine) in ethanol -water mixture by CAT. Background

The September 2004 stench off the southern Malabar coast - A consequence of holococcolithophore bloom

During the third week of September 2004, particularly on 16th and 17th, an unusual and strong stench was reported from the coast at Kollam and Vizhinjam in Kerala (India). Local dailies reported that over 200 children, mostly below 15 years, complained of nausea, chest pain and short periods of breathlessness because of the stench. Many were hospitalized, but were discharged within a couple of hours. A press report stated that the stench was due to dead fish scattered on the beaches and in the water. The report linked the fish death to oxygen depletion and choking of fish gills. Both were reported to be possibly due to proliferation and eventual putrefaction of a fish-toxic alga Cochlodinium polykreikoides. Information was put up on the web that the bloom was caused by Karenia brevis, a toxic dinoflagellate. It was reported that the stench could be felt up to 5 km inland from the coast. On 20 September 2004, the Government of Kerala requested the National Institute of Oceanography (NIO), Goa to determine the cause of the phenomenon. In response, a team from NIO collected near-shore samples of water on 23 and 26 September off Vizhinjam, Shanghumugham and Kollam. During 3-7 October 2004, RV Sagar Sukti, a coastal research vessel of NIO, was used to collect samples in the waters offshore of Vizhinjam, Veli, Kollam in the depth zones of 20-50 m. The water samples collected on 23 and 26 September from the near-shore spots were analysed for various chemical (dissolved oxygen, hydrogen sulphide, nutrients, and salinity) and biological (microbiological, phytoplankton counting and identification) variables. Data from sea-level records at Cochin Port were also examined to learn about the possible evolution of physical conditions before and after the episode described above. In this preliminary report inferences based on analysis of the data is presented

The Enskog Process

The existence of a weak solution to a McKean-Vlasov type stochastic differential system corresponding to the Enskog equation of the kinetic theory of gases is established under natural conditions. The distribution of any solution to the system at each fixed time is shown to be unique. The existence of a probability density for the time-marginals of the velocity is verified in the case where the initial condition is Gaussian, and is shown to be the density of an invariant measure.Comment: 38 page

Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study

Objective: To investigate quality of life (QoL) and association with surgical complexity and disease burden after surgical resection for advanced ovarian cancer in centres with variation in surgical approach. Design: Prospective multicentre observational study. Setting: Gynaecological cancer surgery centres in the UK, Kolkata, India, and Melbourne, Australia. Sample: Patients undergoing surgical resection (with low, intermediate or high surgical complexity score, SCS) for late-stage ovarian cancer. Main Outcome Measures: Primary: change in global score on the European Organisation for Research and Treatment of Cancer (EORTC) core quality-of-life questionnaire (QLQ-C30). Secondary: EORTC ovarian cancer module (OV28), progression-free survival. Results: Patients’ preoperative disease burden and SCS varied between centres, confirming differences in surgical ethos. QoL response rates were 90% up to 18 months. Mean change from the pre-surgical baseline in the EORTC QLQ-C30 was 3.4 (SD 1.8, n = 88) in the low, 4.0 (SD 2.1, n = 55) in the intermediate and 4.3 (SD 2.1, n = 52) in the high-SCS group after 6 weeks (p = 0.048), and 4.3 (SD 2.1, n = 51), 5.1 (SD 2.2, n = 41) and 5.1 (SD 2.2, n = 35), respectively, after 12 months (p = 0.133). In a repeated-measures model, there were no clinically or statistically meaningful differences in EORTC QLQ-C30 global scores between the three SCS groups (p = 0.840), but there was a small statistically significant improvement in all groups over time (p < 0.001). The high-SCS group experienced small to moderate decreases in physical (p = 0.004), role (p = 0.016) and emotional (p = 0.001) function at 6 weeks post-surgery, which resolved by 6–12 months. Conclusions: The global QoL of patients undergoing low-, intermediate- and high-SCS surgery improved at 12 months after surgery and was no worse in patients undergoing extensive surgery